Chengdu SIWI Science and Technology Company Limited Fundamental Analysis
Chengdu SIWI Science and Technology Company Limited Fundamental Analysis
Chengdu SIWI Science and Technology Company Limited (1202.HK) shows weak financial fundamentals with a PE ratio of 169.44, profit margin of 0.81%, and ROE of 0.38%. The company generates $0.4B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 38.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 1202.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak1202.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate1202.HK shows balanced valuation metrics.
Growth Score
Weak1202.HK faces weak or negative growth trends.
Financial Health Score
Excellent1202.HK maintains a strong and stable balance sheet.
Profitability Score
Weak1202.HK struggles to sustain strong margins.
Key Financial Metrics
Is 1202.HK Expensive or Cheap?
P/E Ratio
1202.HK trades at 169.44 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 1202.HK's PEG of -0.41 indicates potential undervaluation.
Price to Book
The market values Chengdu SIWI Science and Technology Company Limited at 0.65 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 77.65 times EBITDA. This signals the market has high growth expectations.
How Well Does 1202.HK Make Money?
Net Profit Margin
For every $100 in sales, Chengdu SIWI Science and Technology Company Limited keeps $0.81 as profit after all expenses.
Operating Margin
Core operations generate 1.14 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.38 in profit for every $100 of shareholder equity.
ROA
Chengdu SIWI Science and Technology Company Limited generates $0.29 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Chengdu SIWI Science and Technology Company Limited generates limited operating cash flow of $-45.88M, signaling weaker underlying cash strength.
Free Cash Flow
Chengdu SIWI Science and Technology Company Limited generates weak or negative free cash flow of $-64.34M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.16 in free cash annually.
FCF Yield
1202.HK converts -12.68% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
169.44
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.41
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.65
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.39
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.01
vs 25 benchmark
Current Ratio
Current assets to current liabilities
6.55
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.004
vs 25 benchmark
ROA
Return on assets percentage
0.003
vs 25 benchmark
ROCE
Return on capital employed
0.005
vs 25 benchmark
How 1202.HK Stacks Against Its Sector Peers
| Metric | 1202.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 169.44 | 35.98 | Worse (Expensive) |
| ROE | 0.38% | 735.00% | Weak |
| Net Margin | 0.81% | -140434.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 0.46 | Strong (Low Leverage) |
| Current Ratio | 6.55 | 3.40 | Strong Liquidity |
| ROA | 0.29% | 179.00% | Weak |
1202.HK outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Chengdu SIWI Science and Technology Company Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta